ScripPfizer Inc. held a 32% stake in Haleon plc after the consumer health business spun out of GSK plc in 2022, but through a sale of stock on 19 March Pfizer reduced its stake to 22.6% and garnered $
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus
In VivoIsrael is well known for punching above its weight in biopharma, with the country’s industry bringing innovation to the sector. In Vivo has spoken to industry leaders there to understand the impact of
ScripFerring Pharmaceuticals has the distinction of winning the first US Food and Drug Administration approval for a microbiota-based drug, just a day after the agency issued a final guidance that should